Schizophrenia (SZ) is a neurodevelopmental disorder affecting 1% of the population worldwide, often resulting in lifelong disability.
1 Treatments are not efficacious for the most disabling symptoms such as deficits in working memory, attention, and social cognition.
2 Understanding the underlying biology of SZ can inform both treatment and prevention strategies. Heritability estimates are high (70%-81%) and some genetic variants have now been identified
3 including multiple common variants,
4,5 copy number variants,
6 and rare mutations.
7,8 The Psychiatric Genomics Consortium has identified 108 loci
9; despite its size, this study has highlighted modest effect sizes and the importance of regulatory DNA.
10 Mechanistic studies in transgenic animals have significant limitations because animal models have different brain structures and cannot fully recapitulate the phenotypic components of SZ.
11